REPORT ID 4915

Global Acute Respiratory Distress Syndrome Therapeutics Market Professional Survey Report 2017

Publish Date
19-Dec-17
Pages
101
Format
Electronic (PDF)

This report studies Acute Respiratory Distress Syndrome Therapeutics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    Therabron Therapeutics, Inc.
    Serendex Pharmaceuticals A/S
    Silence Therapeutics Plc
    Histocell S.L.
    Altor BioScience Corporation
    Athersys, Inc.
    Faron Pharmaceuticals Oy
    FirstString Research, Inc.
    GlaxoSmithKline Plc
    Phylogica Limited

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Methylprednisolone
    Hydrocortisone
    Calf Pulmonary Surfactant for Injection
    Others

By Application, the market can be split into
    In-Patient
    Out-Patient

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Acute Respiratory Distress Syndrome Therapeutics Market Professional Survey Report 2017
1 Industry Overview of Acute Respiratory Distress Syndrome Therapeutics
    1.1 Definition and Specifications of Acute Respiratory Distress Syndrome Therapeutics
        1.1.1 Definition of Acute Respiratory Distress Syndrome Therapeutics
        1.1.2 Specifications of Acute Respiratory Distress Syndrome Therapeutics
    1.2 Classification of Acute Respiratory Distress Syndrome Therapeutics
        1.2.1 Methylprednisolone
        1.2.2 Hydrocortisone
        1.2.3 Calf Pulmonary Surfactant for Injection
        1.2.4 Others
    1.3 Applications of Acute Respiratory Distress Syndrome Therapeutics
        1.3.1 In-Patient
        1.3.2 Out-Patient
        1.3.3 Application 3
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Acute Respiratory Distress Syndrome Therapeutics
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Acute Respiratory Distress Syndrome Therapeutics
    2.3 Manufacturing Process Analysis of Acute Respiratory Distress Syndrome Therapeutics
    2.4 Industry Chain Structure of Acute Respiratory Distress Syndrome Therapeutics

3 Technical Data and Manufacturing Plants Analysis of Acute Respiratory Distress Syndrome Therapeutics
    3.1 Capacity and Commercial Production Date of Global Acute Respiratory Distress Syndrome Therapeutics Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Acute Respiratory Distress Syndrome Therapeutics Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Acute Respiratory Distress Syndrome Therapeutics Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Acute Respiratory Distress Syndrome Therapeutics Major Manufacturers in 2016

4 Global Acute Respiratory Distress Syndrome Therapeutics Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Acute Respiratory Distress Syndrome Therapeutics Capacity and Growth Rate Analysis
        4.2.2 2016 Acute Respiratory Distress Syndrome Therapeutics Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Acute Respiratory Distress Syndrome Therapeutics Sales and Growth Rate Analysis
        4.3.2 2016 Acute Respiratory Distress Syndrome Therapeutics Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Acute Respiratory Distress Syndrome Therapeutics Sales Price
        4.4.2 2016 Acute Respiratory Distress Syndrome Therapeutics Sales Price Analysis (Company Segment)

5 Acute Respiratory Distress Syndrome Therapeutics Regional Market Analysis
    5.1 North America Acute Respiratory Distress Syndrome Therapeutics Market Analysis
        5.1.1 North America Acute Respiratory Distress Syndrome Therapeutics Market Overview
        5.1.2 North America 2012-2017E Acute Respiratory Distress Syndrome Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Acute Respiratory Distress Syndrome Therapeutics Sales Price Analysis
        5.1.4 North America 2016 Acute Respiratory Distress Syndrome Therapeutics Market Share Analysis
    5.2 China Acute Respiratory Distress Syndrome Therapeutics Market Analysis
        5.2.1 China Acute Respiratory Distress Syndrome Therapeutics Market Overview
        5.2.2 China 2012-2017E Acute Respiratory Distress Syndrome Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Acute Respiratory Distress Syndrome Therapeutics Sales Price Analysis
        5.2.4 China 2016 Acute Respiratory Distress Syndrome Therapeutics Market Share Analysis
    5.3 Europe Acute Respiratory Distress Syndrome Therapeutics Market Analysis
        5.3.1 Europe Acute Respiratory Distress Syndrome Therapeutics Market Overview
        5.3.2 Europe 2012-2017E Acute Respiratory Distress Syndrome Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Acute Respiratory Distress Syndrome Therapeutics Sales Price Analysis
        5.3.4 Europe 2016 Acute Respiratory Distress Syndrome Therapeutics Market Share Analysis
    5.4 Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Market Analysis
        5.4.1 Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Market Overview
        5.4.2 Southeast Asia 2012-2017E Acute Respiratory Distress Syndrome Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Acute Respiratory Distress Syndrome Therapeutics Sales Price Analysis
        5.4.4 Southeast Asia 2016 Acute Respiratory Distress Syndrome Therapeutics Market Share Analysis
    5.5 Japan Acute Respiratory Distress Syndrome Therapeutics Market Analysis
        5.5.1 Japan Acute Respiratory Distress Syndrome Therapeutics Market Overview
        5.5.2 Japan 2012-2017E Acute Respiratory Distress Syndrome Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Acute Respiratory Distress Syndrome Therapeutics Sales Price Analysis
        5.5.4 Japan 2016 Acute Respiratory Distress Syndrome Therapeutics Market Share Analysis
    5.6 India Acute Respiratory Distress Syndrome Therapeutics Market Analysis
        5.6.1 India Acute Respiratory Distress Syndrome Therapeutics Market Overview
        5.6.2 India 2012-2017E Acute Respiratory Distress Syndrome Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Acute Respiratory Distress Syndrome Therapeutics Sales Price Analysis
        5.6.4 India 2016 Acute Respiratory Distress Syndrome Therapeutics Market Share Analysis

6 Global 2012-2017E Acute Respiratory Distress Syndrome Therapeutics Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Acute Respiratory Distress Syndrome Therapeutics Sales by Type
    6.2 Different Types of Acute Respiratory Distress Syndrome Therapeutics Product Interview Price Analysis
    6.3 Different Types of Acute Respiratory Distress Syndrome Therapeutics Product Driving Factors Analysis
        6.3.1 Methylprednisolone of Acute Respiratory Distress Syndrome Therapeutics Growth Driving Factor Analysis
        6.3.2 Hydrocortisone of Acute Respiratory Distress Syndrome Therapeutics Growth Driving Factor Analysis
        6.3.3 Calf Pulmonary Surfactant for Injection of Acute Respiratory Distress Syndrome Therapeutics Growth Driving Factor Analysis
        6.3.4 Others of Acute Respiratory Distress Syndrome Therapeutics Growth Driving Factor Analysis

7 Global 2012-2017E Acute Respiratory Distress Syndrome Therapeutics Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Acute Respiratory Distress Syndrome Therapeutics Consumption by Application
    7.2 Different Application of Acute Respiratory Distress Syndrome Therapeutics Product Interview Price Analysis
    7.3 Different Application of Acute Respiratory Distress Syndrome Therapeutics Product Driving Factors Analysis
        7.3.1 In-Patient of Acute Respiratory Distress Syndrome Therapeutics Growth Driving Factor Analysis
        7.3.2 Out-Patient of Acute Respiratory Distress Syndrome Therapeutics Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Acute Respiratory Distress Syndrome Therapeutics
    8.1 Therabron Therapeutics, Inc.
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Therabron Therapeutics, Inc. 2016 Acute Respiratory Distress Syndrome Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Therabron Therapeutics, Inc. 2016 Acute Respiratory Distress Syndrome Therapeutics Business Region Distribution Analysis
    8.2 Serendex Pharmaceuticals A/S
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Serendex Pharmaceuticals A/S 2016 Acute Respiratory Distress Syndrome Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Serendex Pharmaceuticals A/S 2016 Acute Respiratory Distress Syndrome Therapeutics Business Region Distribution Analysis
    8.3 Silence Therapeutics Plc
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Silence Therapeutics Plc 2016 Acute Respiratory Distress Syndrome Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Silence Therapeutics Plc 2016 Acute Respiratory Distress Syndrome Therapeutics Business Region Distribution Analysis
    8.4 Histocell S.L.
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Histocell S.L. 2016 Acute Respiratory Distress Syndrome Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Histocell S.L. 2016 Acute Respiratory Distress Syndrome Therapeutics Business Region Distribution Analysis
    8.5 Altor BioScience Corporation
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Altor BioScience Corporation 2016 Acute Respiratory Distress Syndrome Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Altor BioScience Corporation 2016 Acute Respiratory Distress Syndrome Therapeutics Business Region Distribution Analysis
    8.6 Athersys, Inc.
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Athersys, Inc. 2016 Acute Respiratory Distress Syndrome Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Athersys, Inc. 2016 Acute Respiratory Distress Syndrome Therapeutics Business Region Distribution Analysis
    8.7 Faron Pharmaceuticals Oy
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Faron Pharmaceuticals Oy 2016 Acute Respiratory Distress Syndrome Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Faron Pharmaceuticals Oy 2016 Acute Respiratory Distress Syndrome Therapeutics Business Region Distribution Analysis
    8.8 FirstString Research, Inc.
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 FirstString Research, Inc. 2016 Acute Respiratory Distress Syndrome Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 FirstString Research, Inc. 2016 Acute Respiratory Distress Syndrome Therapeutics Business Region Distribution Analysis
    8.9 GlaxoSmithKline Plc
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 GlaxoSmithKline Plc 2016 Acute Respiratory Distress Syndrome Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 GlaxoSmithKline Plc 2016 Acute Respiratory Distress Syndrome Therapeutics Business Region Distribution Analysis
    8.10 Phylogica Limited
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Phylogica Limited 2016 Acute Respiratory Distress Syndrome Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Phylogica Limited 2016 Acute Respiratory Distress Syndrome Therapeutics Business Region Distribution Analysis

9 Development Trend of Analysis of Acute Respiratory Distress Syndrome Therapeutics Market
    9.1 Global Acute Respiratory Distress Syndrome Therapeutics Market Trend Analysis
        9.1.1 Global 2017-2022 Acute Respiratory Distress Syndrome Therapeutics Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Acute Respiratory Distress Syndrome Therapeutics Sales Price Forecast
    9.2 Acute Respiratory Distress Syndrome Therapeutics Regional Market Trend
        9.2.1 North America 2017-2022 Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast
        9.2.2 China 2017-2022 Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast
        9.2.3 Europe 2017-2022 Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast
        9.2.5 Japan 2017-2022 Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast
        9.2.6 India 2017-2022 Acute Respiratory Distress Syndrome Therapeutics Consumption Forecast
    9.3 Acute Respiratory Distress Syndrome Therapeutics Market Trend (Product Type)
    9.4 Acute Respiratory Distress Syndrome Therapeutics Market Trend (Application)

10 Acute Respiratory Distress Syndrome Therapeutics Marketing Type Analysis
    10.1 Acute Respiratory Distress Syndrome Therapeutics Regional Marketing Type Analysis
    10.2 Acute Respiratory Distress Syndrome Therapeutics International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Acute Respiratory Distress Syndrome Therapeutics by Region
    10.4 Acute Respiratory Distress Syndrome Therapeutics Supply Chain Analysis

11 Consumers Analysis of Acute Respiratory Distress Syndrome Therapeutics
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Acute Respiratory Distress Syndrome Therapeutics Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source